Press Releases | Philochem

2026 Swiss Chemical Society (SCS) Industrial Science Award for Samuele Cazzamalli, Head of Research at Philochem

by Lisa Nadal | Nov 28, 2025 | Press Releases, Scientific

Dr. Samuele Cazzamalli, Head of Research at Philochem, will be awarded the Industrial Science Award 2026 from the Swiss Chemical Society His research has focused on the discovery of novel tumor-targeting diagnostic and therapeutic agents through the use of DNA-Encoded...

Philochem AG Announces Completion of Antitrust Clearance and Closing of the OncoACP3 Licensing Agreement with RayzeBio, a Bristol Myers Squibb Company, With a Potential Value of up to $1.35 Billion Plus Royalties

by Lisa Nadal | Aug 18, 2025 | Investors, Press Releases

For more details

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties.

by Lisa Nadal | Jun 10, 2025 | Press Releases

More details

2024 EFMC Prize for Young Medicinal Chemist or Chemical Biologist in Industry for Samuele Cazzamalli, Head of Chemistry at Philochem

by last | Sep 4, 2024 | 2024, Past Events, Press Releases

Dr. Samuele Cazzamalli, Head of Chemistry at Philochem, will be awarded the 2024 EFMC Prize for Young Medicinal Chemist or Chemical Biologist in Industry. 2024_EFMC_Prize_for Young_Medicinal_Chemist

Philochem AG announces Board of Appeal decision on Philochem’s Patent on Production of Encoded Chemical Libraries

by Lisa Nadal | Feb 21, 2024 | 2024, Press Releases

More details

Philogen announces new publication in Nature Chemistry

by Lisa Nadal | Jul 4, 2023 | Press Releases

The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at the following link. Nat_chem_280223_press_release